Penumbra Inc (PEN)
205.50
-0.65
(-0.32%)
USD |
NYSE |
Apr 25, 16:00
205.71
+0.21
(+0.10%)
Pre-Market: 20:00
Penumbra Research and Development Expense (Quarterly): 21.94M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.94M |
| September 30, 2023 | 20.96M |
| June 30, 2023 | 21.54M |
| March 31, 2023 | 19.99M |
| December 31, 2022 | 17.96M |
| September 30, 2022 | 21.32M |
| June 30, 2022 | 19.56M |
| March 31, 2022 | 20.56M |
| December 31, 2021 | 52.00M |
| September 30, 2021 | 16.73M |
| June 30, 2021 | 17.74M |
| March 31, 2021 | 18.08M |
| December 31, 2020 | 19.46M |
| September 30, 2020 | 34.92M |
| June 30, 2020 | 22.72M |
| March 31, 2020 | 12.95M |
| December 31, 2019 | 12.86M |
| September 30, 2019 | 13.73M |
| June 30, 2019 | 13.46M |
| Date | Value |
|---|---|
| March 31, 2019 | 11.67M |
| December 31, 2018 | 10.87M |
| September 30, 2018 | 9.092M |
| June 30, 2018 | 8.193M |
| March 31, 2018 | 8.013M |
| December 31, 2017 | 8.401M |
| September 30, 2017 | 8.132M |
| June 30, 2017 | 8.094M |
| March 31, 2017 | 7.034M |
| December 31, 2016 | 6.113M |
| September 30, 2016 | 6.497M |
| June 30, 2016 | 6.264M |
| March 31, 2016 | 5.001M |
| December 31, 2015 | 5.484M |
| September 30, 2015 | 4.56M |
| June 30, 2015 | 4.792M |
| March 31, 2015 | 3.191M |
| December 31, 2014 | 4.14M |
| September 30, 2014 | 3.897M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
12.86M
Minimum
Dec 2019
52.00M
Maximum
Dec 2021
20.97M
Average
19.56M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 350.00M |
| Boston Scientific Corp | 363.00M |
| Insulet Corp | 42.00M |
| Shockwave Medical Inc | 42.32M |
| Stereotaxis Inc | 2.212M |